Ayman Rabayah
☆    

Jordan,
2020-04-08 13:23
(2267 d 20:30 ago)

Posting: # 21318
Views: 2,367
 

 Tegaserod analytical method [Regulatives / Guidelines]

Post reply
Hello colleagues
I hope you are in good health and conditions, and wish the the COVID-19 crisis come to end in all countries.
kindly we are developing an analytical method for Tegaserod in human plasma, if you have an experience with this product (6 mg dose), is the metabolite M29 need to be included to be detected and measured, and if an LLOQ of 50 pg/ml will be enough?

looking to hear your advises
Thank you
 
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
117 visitors (0 registered, 117 guests [including 10 identified bots]).
Forum time: 09:54 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5